Viking Global Investors’s Travere Therapeutics TVTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,601,922	Closed	-$46.6M	–	108
2025 Q1	$46.6M	Sell	2,601,922 -300,003	-10%	-$5.38M	0.15%	76
2024 Q4	$50.6M	Buy	+2,901,925	New	+$50.6M	0.16%	72